) disclosed its plan to feature its innovative technologies,
including the company's Fractional Flow Reserve (FFR) and iFR
(Instant Wave-Free Ratio) technologies at the EuroPCR 2013 in
NATUS MEDICAL (BABY): Free Stock Analysis
HEARTWARE INTL (HTWR): Free Stock Analysis
INTUITIVE SURG (ISRG): Free Stock Analysis
VOLCANO CORP (VOLC): Free Stock Analysis
To read this article on Zacks.com click here.
At the EuroPCR, Volcano will also launch its iFR modality and
CORE Integrated System. The company will highlight its Verrata
Pressure Guide Wire at the Paris conference. The Verrata Wire is
not yet commercially available in the U.S. and Europe as its
510(k) clearance and CE Mark approval are pending. Additionally,
Volcano will display currently available as well as future
offerings from its line of physiology, imaging and multi-modality
As per management, the research and development efforts and
innovation reflects Volcano's undertaking in clinical and
technological advancement. The company will also highlight latest
clinical data associated with its functional management
technologies. Volcano's Verrata Wire will be the company's fifth
novel guide wire in five years, reflecting the company's sharp
focus on portfolio expansion.
We are encouraged by Volcano's recent innovation. Notably,
pipeline development at the company is progressing well. Volcano
has been working on expanding its portfolio with the recent
launch of many products. This is expected to boost its revenues
in the long term.
While we are impressed with the company's pipeline development
program, margins still remain under pressure due to the duplicity
of operations in its new facility with the existing one.
Moreover, earlier this month, Volcano reported a mixed quarter in
a challenging scenario. The weakness in yen and slowdown in
percutaneous interventional (PCI) volumes were major headwinds in
the last quarter. Moreover, the company expects the challenges to
persist through 2013 as reflected in the conservative guidance
for the ongoing year.
Accordingly, the stock carries a Zacks Rank #3 (Hold). While we
remain on the sidelines for Volcano,
Natus Medical Inc.
), carrying a Zacks Rank #1 (Strong Buy) warrants a look.
Heartware International Inc.
Intuitive Surgical Inc.
), carrying Zacks Rank #2 (Buy) are also worth considering.